全球藥物釋放型球囊市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，藥物釋放型球囊市場規模將從 2025 年的 18.3 億美元成長至 43.3 億美元，2026 年至 2034 年的複合年成長率為 10.03%。

受心血管疾病盛行率上升和微創治療方法需求成長的推動，全球藥物釋放型球囊（DEB）市場預計將顯著成長。藥物釋放型球囊是一種用於血管成形術的專用醫療設備，可將治療藥物直接輸送到動脈粥狀硬化病變部位，從而降低再血管再阻塞的風險。隨著醫療專業人員尋求治療血管疾病的有效方案，藥物釋放型球囊的應用預計將大幅增加，進而推動該市場的創新和投資。

此外，藥物洗脫球囊（DEB）技術和藥物製劑的進步預計將進​​一步推動藥物釋放型球囊市場的發展。新型藥物組合和球囊設計的研發，提高了DEB的療效和安全性，從而改善了其在臨床應用中的表現。此外，對病患療效和醫療品質的日益重視，也推動了對能夠提供更佳長期療效的先進DEB解決方案的需求。隨著製造商越來越認知到高品質藥物釋放型球囊在實現治療目標方面的重要性，滿足不同患者需求的創新解決方案的需求很可能會激增。

此外，對監管合規性和臨床證據日益重視預計將塑造藥物釋放型球囊市場的未來。隨著監管機構實施更嚴格的醫療設備指南並要求提供可靠的臨床數據，符合這些標準的藥物洗脫球囊的需求將持續成長。藥物洗脫球囊製造商、醫療服務提供者和監管機構之間的合作對於推動這些進步並確保藥物釋放型球囊市場始終處於心血管治療創新領域的前沿至關重要。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

第4章：全球藥物釋放型球囊市場：依產品類型分類

• 市場分析、洞察與預測
• 末梢用藥物釋放型球囊
• 冠狀動脈藥物釋放型球囊
• 其他

第5章：全球藥物釋放型球囊市場：依應用領域分類

• 市場分析、洞察與預測
• 周邊動脈疾病
• 冠狀動脈疾病
• 其他

第6章 全球藥物釋放型球囊市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 專科診所
• 其他

第7章 全球藥物釋放型球囊市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cook Medical
  • Biotronik
  • Abbott Laboratories
  • Terumo Corporation
  • Surmodics Inc
  • Eurocor GmbH
  • Meril Life Sciences Pvt. Ltd
  • Concept Medical Inc
  • MedAlliance SA
  • Biosensors International Group Ltd
  • Cardionovum GmbH
  • Acotec Scientific Co. Ltd

The Drug Eluting Balloon Market size is expected to reach USD 4.33 Billion in 2034 from USD 1.83 Billion (2025) growing at a CAGR of 10.03% during 2026-2034.

The global drug eluting balloon (DEB) market is set to experience substantial growth, driven by the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive treatment options. Drug eluting balloons are specialized medical devices used in angioplasty procedures to deliver therapeutic agents directly to the site of atherosclerotic lesions, reducing the risk of restenosis. As healthcare providers seek effective solutions for treating vascular diseases, the adoption of drug eluting balloons is expected to rise significantly, fostering innovation and investment in this market.

Moreover, advancements in DEB technology and drug formulations are anticipated to further boost the drug eluting balloon market. The development of new drug combinations and balloon designs that enhance the efficacy and safety of DEBs is improving their performance in clinical settings. Additionally, the growing emphasis on patient outcomes and quality of care is driving the demand for advanced DEB solutions that provide better long-term results. As manufacturers increasingly recognize the importance of high-quality drug eluting balloons in achieving therapeutic goals, the market is likely to witness a surge in demand for innovative solutions that cater to diverse patient needs.

In addition, the increasing focus on regulatory compliance and clinical evidence is expected to shape the future of the drug eluting balloon market. As regulatory bodies implement stricter guidelines for medical devices and require robust clinical data, the demand for DEBs that meet these standards will continue to rise. Collaborative efforts between DEB manufacturers, healthcare providers, and regulatory agencies will be essential in driving these advancements, ensuring that the drug eluting balloon market remains at the forefront of cardiovascular treatment innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Peripheral Drug Eluting Balloons
• Coronary Drug Eluting Balloons
• Others

By Application

• Peripheral Artery Disease
• Coronary Artery Disease
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

COMPANIES PROFILED

• Medtronic, Boston Scientific Corporation, B Braun Melsungen AG, Cook Medical, Biotronik, Abbott Laboratories, Terumo Corporation, Surmodics Inc, Eurocor GmbH, Meril Life Sciences Pvt Ltd, Concept Medical Inc, MedAlliance SA, Biosensors International Group Ltd, Cardionovum GmbH, Acotec Scientific Co Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG ELUTING BALLOON MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Peripheral Drug Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Coronary Drug Eluting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG ELUTING BALLOON MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG ELUTING BALLOON MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG ELUTING BALLOON MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG ELUTING BALLOON INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 B. Braun Melsungen AG
  • 9.2.4 Cook Medical
  • 9.2.5 Biotronik
  • 9.2.6 Abbott Laboratories
  • 9.2.7 Terumo Corporation
  • 9.2.8 Surmodics Inc
  • 9.2.9 Eurocor GmbH
  • 9.2.10 Meril Life Sciences Pvt. Ltd
  • 9.2.11 Concept Medical Inc
  • 9.2.12 MedAlliance SA
  • 9.2.13 Biosensors International Group Ltd
  • 9.2.14 Cardionovum GmbH
  • 9.2.15 Acotec Scientific Co. Ltd